Status:
UNKNOWN
Prague Registry of Electric Cardioversion
Lead Sponsor:
Institute for Clinical and Experimental Medicine
Conditions:
Atrial Fibrillation
Atrial Flutter
Eligibility:
All Genders
18+ years
Brief Summary
This single-center observational registry follows contemporary efficacy and short-term complications of elective electric cardioversion.
Eligibility Criteria
Inclusion
- Consecutive out-patients undergoing electric cardioversion for atrial fibrillation, atrial tachycardia, or typical atrial flutter
Exclusion
- Unstable patients with acute conditions requiring unplanned hospitalization
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04919902
Start Date
January 1 2020
End Date
March 31 2025
Last Update
June 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Clinical and Experimental Medicine (IKEM)
Prague, Czechia, 14059